4//SEC Filing
THERASENSE INC 4
Accession 0001267399-04-000031
CIK 0001073695operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 2:37 PM ET
Size
24.9 KB
Accession
0001267399-04-000031
Insider Transaction Report
Form 4
THERASENSE INCTHER
LORTZ W MARK
DirectorCEO, President, Chairman
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$24.00/sh−400,000$9,600,000→ 0 totalExercise: $3.00From: 1988-08-08Exp: 2010-03-17→ Common Stock (400,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$3.20/sh−100,000$320,000→ 0 totalExercise: $23.80From: 1988-08-08Exp: 2011-12-14→ Common Stock (100,000 underlying) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−502,490$13,567,230→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−7,908$213,516→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.80/sh−100,269$681,829→ 0 totalExercise: $20.20From: 1988-08-08Exp: 2014-01-05→ Common Stock (100,269 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$18.00/sh−250,000$4,500,000→ 0 totalExercise: $9.00From: 1988-08-08Exp: 2011-08-03→ Common Stock (250,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$23.00/sh−75,000$1,725,000→ 0 totalExercise: $4.00From: 1988-08-08Exp: 2010-07-31→ Common Stock (75,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$19.91/sh−27,750$552,503→ 0 totalExercise: $7.09From: 1988-08-08Exp: 2013-02-25→ Common Stock (27,750 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$6.51/sh−150,000$976,500→ 0 totalExercise: $20.49From: 1988-08-08Exp: 2012-01-29→ Common Stock (150,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2004-04-05$22.00/sh−50,000$1,100,000→ 0 totalExercise: $5.00From: 1988-08-08Exp: 2010-09-29→ Common Stock (50,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to a merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F2]The shares are held in the name of W. Mark Lortz and Patrice Rae Lortz as trustees of The Lortz Charitable Remainder Unitrust dated March 9, 2004; they were transferred from a revocable trust since the reporting person's last report.
- [F3]This option provided for vesting over a four year period and was cancelled pursuant to the merger agreement between the issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
- [F4]Includes 1,059 shares acquired under the TheraSense, Inc. Employee Stock Purchase Plan on April 2, 2004.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 2:37 PM ET
- Size
- 24.9 KB